Details for New Drug Application (NDA): 019085
✉ Email this page to a colleague
The generic ingredient in ATROVENT is ipratropium bromide. There are eight drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ipratropium bromide profile page.
Summary for 019085
Tradename: | ATROVENT |
Applicant: | Boehringer Ingelheim |
Ingredient: | ipratropium bromide |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019085
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;INHALATION | Strength | 0.018MG/INH | ||||
Approval Date: | Dec 29, 1986 | TE: | RLD: | No |
Expired US Patents for NDA 019085
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Boehringer Ingelheim | ATROVENT | ipratropium bromide | AEROSOL, METERED;INHALATION | 019085-001 | Dec 29, 1986 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription